Results 1 to 10 of about 8,330 (210)

Inmunoterapia local [PDF]

open access: yesAnales del Sistema Sanitario de Navarra, 2008
La inmunoterapia específica, junto con la evitación del alergeno y el tratamiento sintomático, forma parte del tratamiento de la patología alérgica. La modalidad más antigua, más conocida y mejor estudiada es la inmunoterapia subcutánea (ITSC), cuya ...
E. Lasa   +5 more
doaj   +4 more sources

Efecto de la inmunoterapia con alérgenos específicos en pacientes pediátricos con asma atendidos en una institución de salud de Colombia [PDF]

open access: yesBiomédica: revista del Instituto Nacional de Salud, 2021
Introducción. El asma es una enfermedad crónica y potencialmente grave. El 80 % de los casos es de origen alérgico, por lo cual la inmunoterapia específica con alérgenos es una alternativa terapéutica que modula el curso natural de la enfermedad ...
Jorge Andrés Puerto   +3 more
doaj   +2 more sources

Impact of Pre-Treatment Serum Ferritin on Response and Survival in Myelodysplastic Syndromes Treated With Azacytidine: A Multivariate Analysis. [PDF]

open access: yesCancer Med
Elevated serum ferritin levels before treatment with azacytidine are associated with lower response rates and shorter survival in patients with myelodysplastic syndromes. This study supports the early identification of transfusion‐related iron overload to improve treatment planning.
Carrasco GM   +8 more
europepmc   +2 more sources

Immunotherapy using pullulan-conjugated Der f 2 allergen in canine atopic dermatitis: An anti-inflammatory agent-sparing approach. [PDF]

open access: yesVet Dermatol
Background – Allergen immunotherapy is used as aetiological treatment for canine atopic dermatitis (cAD). Objective – To assess the anti‐inflammatory agent‐sparing effect over 1 year of immunotherapy using pullulan‐conjugated recombinant Der f 2 (rDf2‐P). Conclusions and Clinical Relevance – Der f 2‐P immunotherapy can lead to a rapid reduction in anti‐
Nagata M   +7 more
europepmc   +2 more sources

Nuevas formas farmacéuticas para el tratamiento de enfermedades alérgicas [PDF]

open access: yesAnales del Sistema Sanitario de Navarra, 2012
La inmunoterapia para el tratamiento de enfermedades alérgicas implica ciertas desventajas, que pueden ser reducidas si se emplean adyuvantes adecuados, que sean capaces de amplificar la respuesta inmune con un efecto alergénico mínimo.
M. Ferrer Puga   +5 more
doaj   +2 more sources

Inmunoterapia en hematología [PDF]

open access: yes, 2008
Inclou referències ...
Besalduch Vidal, Juan
openaire   +2 more sources

Endocrinopatías por inmunoterapia oncológica

open access: yesRevista del Hospital Italiano de Buenos Aires, 2020
La relación entre inmunidad y cáncer es compleja. Las células tumorales desarrollan mecanismos de evasión a las respuestas del sistema inmunitario. Esta capacidad permite su supervivencia y crecimiento.
Ester Gabriela Scheinfeld   +2 more
doaj   +2 more sources

Modified rush venom immunotherapy in dogs with Hymenoptera hypersensitivity

open access: yesVeterinary Dermatology, Volume 34, Issue 6, Page 532-542, December 2023., 2023
Background – Hymenoptera envenomation occurs frequently in people and dogs and can trigger anaphylaxis. Venom immunotherapy (VIT) is the only preventative treatment for Hymenoptera hypersensitivity and is indicated for people with severe adverse reactions to insect stings. Rush VIT is an accelerated VIT induction schedule performed in people.
Alexandra Moore   +4 more
wiley   +1 more source

The safety of rush immunotherapy in the management of canine atopic dermatitis—230 cases

open access: yesVeterinary Dermatology, Volume 34, Issue 5, Page 385-392, October 2023., 2023
Background – The duration of the induction phase of allergen‐specific immunotherapy conventionally is a period of several weeks, during which the volume of an allergen solution, administered by injection, is gradually increased until the maintenance dose is reached.
Tamara Weitzer, Ralf Mueller
wiley   +1 more source

Toxicity evaluation of ConvitVax breast cancer immunotherapy

open access: yesScientific Reports, 2021
ConvitVax is a personalized vaccine for the treatment of breast cancer, composed of autologous tumor cells, bacillus Calmette-Guérin (BCG) and low concentrations of formalin.
María A. Duarte C.   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy